Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1964 1
1965 1
1966 1
1967 2
1972 2
1975 2
1976 1
1977 6
1978 3
1979 3
1980 2
1981 3
1982 2
1983 3
1984 3
1985 5
1987 5
1988 5
1989 1
1990 4
1991 3
1992 7
1993 3
1994 3
1995 4
1996 6
1997 4
1998 4
1999 4
2000 3
2001 3
2002 5
2003 3
2004 3
2005 3
2006 4
2007 2
2008 3
2009 6
2010 10
2011 5
2012 3
2013 5
2014 6
2015 6
2016 3
2017 4
2018 12
2019 7
2020 10
2021 3
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
Liu Y, Cui Y, Zhou Z, Liu B, Liu Z, Li G. Liu Y, et al. Dis Markers. 2023 Feb 21;2023:1316821. doi: 10.1155/2023/1316821. eCollection 2023. Dis Markers. 2023. PMID: 36865500 Free PMC article.
OBJECTIVE: To investigate the relationship between angiotensin II (Ang II), vascular endothelial growth factor (VEGF), and arteriosclerosis obliterans (ASO). METHODS: 60 ASO patients diagnosed and treated from October 2019 to December 2021 were selected for the o …
OBJECTIVE: To investigate the relationship between angiotensin II (Ang II), vascular endothelial growth factor (VEGF), and arterioscleros …
Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity.
Wakabayashi D, Kato S, Tanaka M, Yamakage H, Kato H, Kusakabe T, Ozu N, Kasama S, Kasahara M, Satoh-Asahara N; Japan Obesity Metabolic Syndrome Study (JOMS) Group. Wakabayashi D, et al. Diabetes Res Clin Pract. 2023 Nov;205:110919. doi: 10.1016/j.diabres.2023.110919. Epub 2023 Sep 22. Diabetes Res Clin Pract. 2023. PMID: 37742802
During the study period, 15 coronary heart disease, 7 stroke, and 6 arteriosclerosis obliterans events occurred in 39 patients. The CVD incidence rate was 15.8 per 1000 person-years. ...Additionally, we estimated the association between SUA levels and CVD events usi …
During the study period, 15 coronary heart disease, 7 stroke, and 6 arteriosclerosis obliterans events occurred in 39 patients …
Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
Su X, Yuan X, Li F, Yang G, Du L, Zhao F, Zhao R, Ou M. Su X, et al. PeerJ. 2023 Sep 19;11:e16057. doi: 10.7717/peerj.16057. eCollection 2023. PeerJ. 2023. PMID: 37744231 Free PMC article.
OBJECTIVE: Our study aims to investigate the long non-coding RNA plasmacytoma variant translocation 1 (lncRNA PVT1) in lower extremity arteriosclerosis obliterans (LEASO) patient serum and its clinical significance in LEASO. ...Logistic regression analysis suggested …
OBJECTIVE: Our study aims to investigate the long non-coding RNA plasmacytoma variant translocation 1 (lncRNA PVT1) in lower extremity ar …
Brachial-ankle pulse wave velocity, cardio-ankle vascular index, and prognosis.
Ato D. Ato D. Vasc Health Risk Manag. 2018 Oct 24;14:321-348. doi: 10.2147/VHRM.S179366. eCollection 2018. Vasc Health Risk Manag. 2018. PMID: 30498357 Free PMC article. Review.
Multivariate analysis demonstrated that log (number of patients) (OR 11.20, 95% CI 2.45-51.70, P=0.002) and dialysis population (OR 0.28, 95% CI 0.08-0.94, P=0.039) were positive and negative independent determinants of the success of prognostic prediction, respectively. I …
Multivariate analysis demonstrated that log (number of patients) (OR 11.20, 95% CI 2.45-51.70, P=0.002) and dialysis population (OR 0.28, 95 …
Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans.
Yuan YY, Cao WD, Zhang XH, Du RX, Wang XQ, Li J, Chen J, Yang JZ, Chen JQ. Yuan YY, et al. J Health Popul Nutr. 2023 Oct 27;42(1):115. doi: 10.1186/s41043-023-00454-7. J Health Popul Nutr. 2023. PMID: 37891631 Free PMC article. Review.
OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO). METHODS: The E-coach chronic disease management model was constructed based on a li …
OBJECTIVE: To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patien …
Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
Lian W, Nie H, Yuan Y, Wang K, Chen W, Ding L. Lian W, et al. J Invest Surg. 2021 Jul;34(7):765-770. doi: 10.1080/08941939.2019.1690600. Epub 2020 Jan 29. J Invest Surg. 2021. PMID: 31996054
OBJECTIVE: This study aims to investigate the role of endothelin-1 (ET-1) and C-reactive protein (CRP) in restenosis after intervention of lower extremity arteriosclerosis obliterans. METHODS: The present prospective observational study included a total of 25 …
OBJECTIVE: This study aims to investigate the role of endothelin-1 (ET-1) and C-reactive protein (CRP) in restenosis after intervention of l …
Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans.
Ye M, Qian X, Guo X, Wang H, Ni Q, Zhao Y, Xue G, Deng H, Zhang L. Ye M, et al. Ann Vasc Surg. 2020 Apr;64:221-227. doi: 10.1016/j.avsg.2019.09.005. Epub 2019 Oct 23. Ann Vasc Surg. 2020. PMID: 31655109 Free article.
Here, we aimed to determine the association between these ratios and disease severity and evaluate predictive validity of the NLR and PLR in lower limb arteriosclerosis obliterans (ASO). ...RESULTS: Both the NLR and PLR showed significant values on predict …
Here, we aimed to determine the association between these ratios and disease severity and evaluate predictive validity of the NLR and …
Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
Zhao H, Zhuo T, Hao X, Fan X, Zhao P. Zhao H, et al. Ann Palliat Med. 2022 Aug;11(8):2720-2729. doi: 10.21037/apm-22-827. Ann Palliat Med. 2022. PMID: 36064362 Free article.
BACKGROUND: Lower extremity arteriosclerosis obliterans (LEASO) is a chronic progressive disease with clinical manifestations such as intermittent claudication, resting pain, and even ulceration or necrosis of the lower extremities caused by insufficient blood suppl …
BACKGROUND: Lower extremity arteriosclerosis obliterans (LEASO) is a chronic progressive disease with clinical manifestations …
Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients.
Alonso MN, Mata-Forte T, García-León N, Vullo PA, Ramirez-Olivencia G, Estébanez M, Álvarez-Marcos F. Alonso MN, et al. Vasc Health Risk Manag. 2020 Nov 24;16:467-478. doi: 10.2147/VHRM.S276530. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 33262599 Free PMC article.
We have described four different clinical patterns of acroischemia: atypical Raynauds phenomenon (ARP), (4); pseudo-pernio (PP), (5); severe microcirculatory ischemia with preserved pulse (SMI), (6); and dry gangrene with arteriosclerosis obliterans (AO), (9). Kenda …
We have described four different clinical patterns of acroischemia: atypical Raynauds phenomenon (ARP), (4); pseudo-pernio (PP), (5); severe …
Systemic Immune-Inflammation Index Predicts Restenosis after Interventions for Lower Extremity Arteriosclerosis Obliterans.
Tian SY. Tian SY. Heart Surg Forum. 2023 May 31;26(3):E225-E233. doi: 10.1532/hsf.5303. Heart Surg Forum. 2023. PMID: 37401437
BACKGROUND: To investigate the association between the pretreatment systemic immune-inflammation index (SII) and restenosis after interventions for lower extremity arteriosclerosis obliterans (ASO). METHODS: We retrospectively evaluated 309 patients with ASO who und …
BACKGROUND: To investigate the association between the pretreatment systemic immune-inflammation index (SII) and restenosis after interventi …
196 results